Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZD6126 + FOLFOX in Metastatic Colorectal Cancer
NCT00065117Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Sep 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZD6126 in colorectal cancer (metastatic) (mCRC), sponsored by AstraZeneca. Started Sep 2003; status: terminated.
02
Drugs
ZD6126
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00065117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065117.